Exopharm (ASX:EX1) is a leader in exosome technology and holds a portfolio of intellectual property and know-how related to exosomes and the manufacture of exosomes.
Exosomes could be an alternative means of drug-delivery inside the body, alongside technologies such as lipid nanoparticles (LNP), cell-penetrating peptides, viral vectors and liposomes.
Exopharm’s exosome technologies solve important needs for the success of exosome medicines – LEAP manufacturing technology, LOAD API loading technologies and EVPS tropism technologies.
Exosome-based medicines could improve the treatment of many chronic or inherited medical conditions.
Exopharm is making its proprietary technologies available to pharmaceutical and biotechnology companies that want to harness exosome-delivery for their own products.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Melbourne, Melbourne,vic,australia
- Phone
- +61 (0)3 9111 0026
- in****@****arm.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- exopharm.com
- Keywords
- Extracellular vesicles, exosomes, biotechnology, ligand-based affinity chromatography, cell engineering.
- HQ
- Melbourne, VIC
Exopharm Ltd Questions
Exopharm Ltd's helpline number is +61 (0)3 9111 0026
Exopharm Ltd's website is exopharm.com
Exopharm Ltd's LinkedIn profile is https://au.linkedin.com/company/exopharm
Exopharm Ltd has
6 employees.
View email and phone details for 6
employees at Exopharm Ltd.
Exopharm Ltd's industry is
Biotechnology Research
Exopharm Ltd's top competitors are
Lateral Pharma Pty Ltd,
Audax Biosciences,
Biocurate Pty Ltd,
Everzom,
Inoviq Ltd (Asx:iiq),
Exosomics Spa,
Cell Therapies Pty Ltd,
Exocobio,
Capricor Therapeutics, Inc.,
Aegle Therapeutics.
Exopharm Ltd's support email address is info@exopharm.com
Exopharm Ltd's categories are Biotechnology Research
Exopharm Ltd's founding year is 2013
